Susquehanna International Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $396K | Buy |
57,300
+15,200
| +36% | +$117K | ﹤0.01% | 10245 |
|
|
2025
Q4 | $371K | Sell |
42,100
-46,900
| -53% | -$258K | ﹤0.01% | 9461 |
|
|
2025
Q3 | $444K | Sell |
89,000
-144,900
| -62% | -$671K | ﹤0.01% | 9230 |
|
|
2025
Q2 | $1.1M | Buy |
233,900
+45,800
| +24% | +$200K | ﹤0.01% | 7176 |
|
|
2025
Q1 | $863K | Buy |
188,100
+168,400
| +855% | +$785K | ﹤0.01% | 7621 |
|
|
2024
Q4 | $94.4K | Buy |
19,700
+7,200
| +58% | +$34.6K | ﹤0.01% | 11381 |
|
|
2024
Q3 | $58.6K | Sell |
12,500
-132,100
| -91% | -$708K | ﹤0.01% | 11317 |
|
|
2024
Q2 | $817K | Buy |
144,600
+77,700
| +116% | +$401K | ﹤0.01% | 7068 |
|
|
2024
Q1 | $275K | Buy |
+66,900
| New | +$268K | ﹤0.01% | 9893 |
|
|
2023
Q4 | – | Sell |
-10,700
| Closed | -$46.2K | – | 13379 |
|
|
2023
Q3 | $46.2K | Buy |
+10,700
| New | +$59.5K | ﹤0.01% | 11335 |
|
|
2023
Q1 | – | Sell |
-37,100
| Closed | -$274K | – | 13566 |
|
|
2022
Q4 | $274K | Buy |
37,100
+17,300
| +87% | +$168K | ﹤0.01% | 9307 |
|
|
2022
Q3 | $196K | Buy |
19,800
+9,600
| +94% | +$101K | ﹤0.01% | 10873 |
|
|
2022
Q2 | $111K | Sell |
10,200
-40,700
| -80% | -$422K | ﹤0.01% | 11384 |
|
|
2022
Q1 | $576K | Sell |
50,900
-98,900
| -66% | -$1.3M | ﹤0.01% | 8609 |
|
|
2021
Q4 | $2.35M | Buy |
149,800
+122,200
| +443% | +$2.13M | ﹤0.01% | 5124 |
|
|
2021
Q3 | $473K | Sell |
27,600
-45,400
| -62% | -$795K | ﹤0.01% | 9534 |
|
|
2021
Q2 | $1.57M | Sell |
73,000
-28,100
| -28% | -$503K | ﹤0.01% | 6521 |
|
|
2021
Q1 | $1.52M | Buy |
101,100
+71,600
| +243% | +$1.16M | ﹤0.01% | 6608 |
|
|
2020
Q4 | $388K | Sell |
29,500
-65,300
| -69% | -$786K | ﹤0.01% | 8797 |
|
|
2020
Q3 | $916K | Sell |
94,800
-240,700
| -72% | -$2.57M | ﹤0.01% | 6323 |
|
|
2020
Q2 | $3.84M | Buy |
335,500
+222,200
| +196% | +$2.52M | ﹤0.01% | 3391 |
|
|
2020
Q1 | $1.17M | Sell |
113,300
-12,300
| -10% | -$153K | ﹤0.01% | 5032 |
|
|
2019
Q4 | $2.06M | Buy |
125,600
+32,700
| +35% | +$494K | ﹤0.01% | 4273 |
|
|
2019
Q3 | $1.23M | Buy |
92,900
+47,400
| +104% | +$661K | ﹤0.01% | 5244 |
|
|
2019
Q2 | $641K | Buy |
45,500
+10,000
| +28% | +$159K | ﹤0.01% | 6724 |
|
|
2019
Q1 | $653K | Buy |
+35,500
| New | +$809K | ﹤0.01% | 5790 |
|
|
2018
Q4 | – | Sell |
-11,100
| Closed | -$255K | – | 10053 |
|
|
2018
Q3 | $255K | Sell |
11,100
-4,400
| -28% | -$89.8K | ﹤0.01% | 7787 |
|
|
2018
Q2 | $295K | Sell |
15,500
-81,700
| -84% | -$1.37M | ﹤0.01% | 7886 |
|
|
2018
Q1 | $1.64M | Buy |
+97,200
| New | +$1.63M | ﹤0.01% | 4296 |
|
|
2017
Q4 | – | Sell |
-49,200
| Closed | -$881K | – | 9960 |
|
|
2017
Q3 | $881K | Buy |
49,200
+26,900
| +121% | +$450K | ﹤0.01% | 5500 |
|
|
2017
Q2 | $363K | Sell |
22,300
-10,400
| -32% | -$150K | ﹤0.01% | 7229 |
|
|
2017
Q1 | $458K | Sell |
32,700
-228,000
| -87% | -$3.25M | ﹤0.01% | 6646 |
|
|
2016
Q4 | $4.16M | Sell |
260,700
-47,800
| -15% | -$768K | ﹤0.01% | 2732 |
|
|
2016
Q3 | $5.13M | Buy |
308,500
+257,900
| +510% | +$3.47M | ﹤0.01% | 2205 |
|
|
2016
Q2 | $566K | Sell |
50,600
-14,700
| -23% | -$142K | ﹤0.01% | 5915 |
|
|
2016
Q1 | $546K | Sell |
65,300
-26,200
| -29% | -$215K | ﹤0.01% | 6239 |
|
|
2015
Q4 | $852K | Buy |
91,500
+1,700
| +2% | +$17K | ﹤0.01% | 5743 |
|
|
2015
Q3 | $1.01M | Sell |
89,800
-97,800
| -52% | -$1.2M | ﹤0.01% | 5723 |
|
|
2015
Q2 | $2.38M | Buy |
187,600
+110,400
| +143% | +$1.19M | ﹤0.01% | 4343 |
|
|
2015
Q1 | $718K | Buy |
77,200
+2,400
| +3% | +$27.1K | ﹤0.01% | 6409 |
|
|
2014
Q4 | $1.07M | Sell |
74,800
-40,400
| -35% | -$478K | ﹤0.01% | 5736 |
|
|
2014
Q3 | $1.2M | Sell |
115,200
-30,600
| -21% | -$401K | ﹤0.01% | 5597 |
|
|
2014
Q2 | $2.36M | Sell |
145,800
-118,200
| -45% | -$1.57M | ﹤0.01% | 4342 |
|
|
2014
Q1 | $4.29M | Sell |
264,000
-216,300
| -45% | -$3.08M | ﹤0.01% | 3101 |
|
|
2013
Q4 | $5.96M | Buy |
480,300
+122,600
| +34% | +$1.23M | ﹤0.01% | 2696 |
|
|
2013
Q3 | $3.92M | Buy |
357,700
+180,600
| +102% | +$1.93M | ﹤0.01% | 3069 |
|
|
2013
Q2 | $1.43M | Buy |
+177,100
| New | +$1.19M | ﹤0.01% | 4422 |
|
Other funds holding VNDA
ACM
VCM
Susquehanna International Group's VNDA Position: Q1 2026 in Review
Susquehanna International Group reduced its Vanda Pharmaceuticals (VNDA) stake by 46% in Q1 2026, selling an estimated $674K and leaving 103,202 shares worth $713K. The position accounts for ﹤0.01% of the portfolio, ranked #8771.
Susquehanna International Group first reported a position in VNDA in Q2 2013 and has held it in 45 quarters since. The position peaked at $3.23M in Q1 2019. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.
- Susquehanna International Group held 103,202 shares of Vanda Pharmaceuticals worth $713K as of Q1 2026.
- Susquehanna International Group sold 87,420 Vanda Pharmaceuticals shares in Q1 2026, an estimated $674K.
- Vanda Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8771 holding.
- Susquehanna International Group first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 45 quarters since.
- Susquehanna International Group's Vanda Pharmaceuticals position peaked at $3.23M in Q1 2019.
- 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.